Executive Summary

The Legal section discusses case law, legislation and our work experience on topics of interest to the pharmaceutical industry. After reading this section, you should be familiar with the more significant judicial decisions, regulatory considerations, as well as the processes that may accompany business activities relating to Market Access.

We describe Brexit and GDPR, as well as broad legal topics such as marketing exclusivity and competition. Cases from around Europe and the CJEU are broken down in detail so MAP members can build their knowledge of the laws affecting their products.